Ultrasound-induced apoptosis in the presence of Sonazoid and associated alterations in gene expression levels: A possible therapeutic application

Yukihiro Furusawa, Qing Li Zhao, Mariame Ali Hassan, Yoshiaki Tabuchi, Ichiro Takasaki, Shigehito Wada, Takashi Kondo

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Ultrasound (US) has been shown to induce apoptosis and cell lysis in cancer cells. In this study, we report on the potential of using Sonazoid, a new echo-contrast agent, that is chemically more stable and US-resistant in combination with US in cancer therapy. The biological effects and their mechanisms in the presence or absence of ultrasonic exposure in vitro were investigated. In addition, the impact of the agent on the expression levels of genes responsive to US was studied using global-scale microarrays and computational gene expression analysis tools. Our results show that the combination led to enhanced cell killing in the presence of 1 MHz acoustic field. The apoptosis induction was shown to be mediated by the mitochondrial pathway. The occurrence of US-induced DNA damage was also observed. Despite these findings, the agent at concentrations similar to those clinically used can be considered as well tolerated. Furthermore, Sonazoid enhanced expression of genes that related to apoptosis and are responsive to US, although it alone had almost no effect. These results indicate the potential of Sonazoid for US contrast enhancement as well as the possibility of its use in US-aided therapies.

Original languageEnglish
Pages (from-to)107-115
Number of pages9
JournalCancer Letters
Volume288
Issue number1
DOIs
Publication statusPublished - 2010 Feb 1

Fingerprint

Apoptosis
Gene Expression
Acoustics
Ultrasonics
Contrast Media
DNA Damage
Neoplasms
Therapeutics
Sonazoid
In Vitro Techniques

Keywords

  • Apoptosis
  • GeneChip analysis
  • Low-intensity ultrasound
  • Sonazoid

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Ultrasound-induced apoptosis in the presence of Sonazoid and associated alterations in gene expression levels : A possible therapeutic application. / Furusawa, Yukihiro; Zhao, Qing Li; Hassan, Mariame Ali; Tabuchi, Yoshiaki; Takasaki, Ichiro; Wada, Shigehito; Kondo, Takashi.

In: Cancer Letters, Vol. 288, No. 1, 01.02.2010, p. 107-115.

Research output: Contribution to journalArticle

Furusawa, Yukihiro ; Zhao, Qing Li ; Hassan, Mariame Ali ; Tabuchi, Yoshiaki ; Takasaki, Ichiro ; Wada, Shigehito ; Kondo, Takashi. / Ultrasound-induced apoptosis in the presence of Sonazoid and associated alterations in gene expression levels : A possible therapeutic application. In: Cancer Letters. 2010 ; Vol. 288, No. 1. pp. 107-115.
@article{b72f7cc8aff84fc6b72788d7b0da3cdd,
title = "Ultrasound-induced apoptosis in the presence of Sonazoid and associated alterations in gene expression levels: A possible therapeutic application",
abstract = "Ultrasound (US) has been shown to induce apoptosis and cell lysis in cancer cells. In this study, we report on the potential of using Sonazoid, a new echo-contrast agent, that is chemically more stable and US-resistant in combination with US in cancer therapy. The biological effects and their mechanisms in the presence or absence of ultrasonic exposure in vitro were investigated. In addition, the impact of the agent on the expression levels of genes responsive to US was studied using global-scale microarrays and computational gene expression analysis tools. Our results show that the combination led to enhanced cell killing in the presence of 1 MHz acoustic field. The apoptosis induction was shown to be mediated by the mitochondrial pathway. The occurrence of US-induced DNA damage was also observed. Despite these findings, the agent at concentrations similar to those clinically used can be considered as well tolerated. Furthermore, Sonazoid enhanced expression of genes that related to apoptosis and are responsive to US, although it alone had almost no effect. These results indicate the potential of Sonazoid for US contrast enhancement as well as the possibility of its use in US-aided therapies.",
keywords = "Apoptosis, GeneChip analysis, Low-intensity ultrasound, Sonazoid",
author = "Yukihiro Furusawa and Zhao, {Qing Li} and Hassan, {Mariame Ali} and Yoshiaki Tabuchi and Ichiro Takasaki and Shigehito Wada and Takashi Kondo",
year = "2010",
month = "2",
day = "1",
doi = "10.1016/j.canlet.2009.06.029",
language = "English",
volume = "288",
pages = "107--115",
journal = "Cancer Letters",
issn = "0304-3835",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Ultrasound-induced apoptosis in the presence of Sonazoid and associated alterations in gene expression levels

T2 - A possible therapeutic application

AU - Furusawa, Yukihiro

AU - Zhao, Qing Li

AU - Hassan, Mariame Ali

AU - Tabuchi, Yoshiaki

AU - Takasaki, Ichiro

AU - Wada, Shigehito

AU - Kondo, Takashi

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Ultrasound (US) has been shown to induce apoptosis and cell lysis in cancer cells. In this study, we report on the potential of using Sonazoid, a new echo-contrast agent, that is chemically more stable and US-resistant in combination with US in cancer therapy. The biological effects and their mechanisms in the presence or absence of ultrasonic exposure in vitro were investigated. In addition, the impact of the agent on the expression levels of genes responsive to US was studied using global-scale microarrays and computational gene expression analysis tools. Our results show that the combination led to enhanced cell killing in the presence of 1 MHz acoustic field. The apoptosis induction was shown to be mediated by the mitochondrial pathway. The occurrence of US-induced DNA damage was also observed. Despite these findings, the agent at concentrations similar to those clinically used can be considered as well tolerated. Furthermore, Sonazoid enhanced expression of genes that related to apoptosis and are responsive to US, although it alone had almost no effect. These results indicate the potential of Sonazoid for US contrast enhancement as well as the possibility of its use in US-aided therapies.

AB - Ultrasound (US) has been shown to induce apoptosis and cell lysis in cancer cells. In this study, we report on the potential of using Sonazoid, a new echo-contrast agent, that is chemically more stable and US-resistant in combination with US in cancer therapy. The biological effects and their mechanisms in the presence or absence of ultrasonic exposure in vitro were investigated. In addition, the impact of the agent on the expression levels of genes responsive to US was studied using global-scale microarrays and computational gene expression analysis tools. Our results show that the combination led to enhanced cell killing in the presence of 1 MHz acoustic field. The apoptosis induction was shown to be mediated by the mitochondrial pathway. The occurrence of US-induced DNA damage was also observed. Despite these findings, the agent at concentrations similar to those clinically used can be considered as well tolerated. Furthermore, Sonazoid enhanced expression of genes that related to apoptosis and are responsive to US, although it alone had almost no effect. These results indicate the potential of Sonazoid for US contrast enhancement as well as the possibility of its use in US-aided therapies.

KW - Apoptosis

KW - GeneChip analysis

KW - Low-intensity ultrasound

KW - Sonazoid

UR - http://www.scopus.com/inward/record.url?scp=73649145879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73649145879&partnerID=8YFLogxK

U2 - 10.1016/j.canlet.2009.06.029

DO - 10.1016/j.canlet.2009.06.029

M3 - Article

C2 - 19646810

AN - SCOPUS:73649145879

VL - 288

SP - 107

EP - 115

JO - Cancer Letters

JF - Cancer Letters

SN - 0304-3835

IS - 1

ER -